(CCAP) Crescent Capital BDC - Ratings and Ratios
Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US2256551092
CCAP: Loans, Equity, Private Equity, Buyouts
Crescent Capital BDC, Inc. (NASDAQ: CCAP) is a Business Development Company (BDC) operating within the asset management sector, specializing in private equity, buyouts, and loan investments. The firm primarily targets middle-market companies in the United States, focusing on direct investments to generate returns through a combination of interest income and capital appreciation. As a BDC, Crescent Capital is structured to provide financing solutions to businesses that may not have access to traditional capital markets, often taking an active role in guiding portfolio companies toward growth and operational efficiency.
Looking ahead, Crescent Capital BDC is well-positioned to capitalize on market opportunities, given its current valuation metrics. With a market capitalization of $706.02 million and a price-to-earnings (P/E) ratio of 7.44, the company is trading at a discount relative to its forward P/E of 9.80, suggesting potential upside as earnings materialize. The price-to-book (P/B) ratio of 0.99 indicates that the market is pricing the company close to its book value, which may present a compelling entry point for investors. Additionally, the return on equity (RoE) of 12.62% highlights the companys ability to generate strong earnings from shareholders equity. With a price-to-sales (P/S) ratio of 3.51, Crescent Capital appears reasonably valued relative to its revenue. As interest rates rise, the companys focus on floating-rate debt investments could further enhance its net interest income, making it an attractive option for investors seeking exposure to the middle-market lending space.
Additional Sources for CCAP Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
CCAP Stock Overview
Market Cap in USD | 582m |
Sector | Financial Services |
Industry | Asset Management |
GiC Sub-Industry | Asset Management & Custody Banks |
IPO / Inception | 2020-02-03 |
CCAP Stock Ratings
Growth 5y | 76.9% |
Fundamental | 45.9% |
Dividend | 77.1% |
Rel. Strength | -11.1 |
Analysts | 4.33/5 |
Fair Price Momentum | 15.72 USD |
Fair Price DCF | 50.59 USD |
CCAP Dividends
Dividend Yield 12m | 12.83% |
Yield on Cost 5y | 31.49% |
Annual Growth 5y | 4.46% |
Payout Consistency | 100.0% |
CCAP Growth Ratios
Growth Correlation 3m | -71.8% |
Growth Correlation 12m | 63.1% |
Growth Correlation 5y | 84.1% |
CAGR 5y | 17.59% |
CAGR/Max DD 5y | 0.56 |
Sharpe Ratio 12m | 1.35 |
Alpha | -3.78 |
Beta | 0.880 |
Volatility | 15.90% |
Current Volume | 532.4k |
Average Volume 20d | 120.6k |
As of April 09, 2025, the stock is trading at USD 14.63 with a total of 532,377 shares traded.
Over the past week, the price has changed by -14.54%, over one month by -13.71%, over three months by -20.13% and over the past year by -4.62%.
Partly, yes. Based on ValueRay Fundamental Analyses, Crescent Capital BDC (NASDAQ:CCAP) is currently (April 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 45.92 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CCAP as of April 2025 is 15.72. This means that CCAP is currently overvalued and has a potential downside of 7.45%.
Crescent Capital BDC has received a consensus analysts rating of 4.33. Therefor, it is recommend to buy CCAP.
- Strong Buy: 3
- Buy: 2
- Hold: 1
- Sell: 0
- Strong Sell: 0
According to ValueRays Forecast Model, CCAP Crescent Capital BDC will be worth about 17.4 in April 2026. The stock is currently trading at 14.63. This means that the stock has a potential upside of +18.93%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 19.7 | 34.4% |
Analysts Target Price | 19.7 | 34.4% |
ValueRay Target Price | 17.4 | 18.9% |